Griffiths lab at Boston University and NEIDL. We work to develop medical countermeasures for highly pathogenic viruses and understand their pathogenesis.
#Ebola virus disease has a high case–fatality rate; there are no approved specific medical countermeasures, but adequate supportive and intensive care can improve outcomes.
https://t.co/5UtJfkXtst
Congratulations to associate professor of microbiology, Anthony Griffiths, PhD, on being awarded a @CEPIvaccines grant. These funds will support the development of vaccines against the highly deadly Nipah virus. More information here: https://t.co/9tLolluJD3
We are thrilled to share our new publication in @SciImmunology including preclinical data showing that our #antibody cocktail is active across #COVID19 variants of concern, including #Omicron#subvariants. Read it here: https://t.co/Gl7VDd318Q
It seems like almost every day there is another major discovery of broad, neutralizing antibodies to #SARSCoV2 that could be the foundation for pan-β-coronavirus vaccines
Yesterday
https://t.co/53pFFnNx9g
Today
https://t.co/rGEXabRCJF
IMM-BCP-01, a patient-derived anti-SARS-CoV-2 antibody cocktail, is active across variants of concern including Omicron BA.1 and BA.2 https://t.co/pe2Buz74VZ
Our most recent work on the full SARS-CoV-2 RNA genome structure in cells @biorxivpreprint ! Special thanks to our collaborators, the @GriffithslabBU.
https://t.co/fLdSR4pvhi
Excited to be part of the first #coronavirus meeting, with George Daley, dean of @Harvardmed, joined by @ragoninstitute scientists, @MIT and @BU scientists, the hospitals, Moderna, and many others as we bring the Boston-Cambridge research community together to combat this.
This is an excellent introduction to #Ebola virus disease. Thanks to all the co authors: @guru_uhuru, Ian Crozier, @WFischerII, @hewlett_angela, @colleenkraftmd, Marc-Antoine de La Vega, @mjsoka, Victoria Wahl and Laura Bollinger. Special Thanks to chief cat-herder Jens Kuhn.